These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 7295100

  • 1. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL.
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [Abstract] [Full Text] [Related]

  • 2. Analytical study for separation of middle molecules.
    Saito A, Kanazawa I, Chung TG, Maeda K.
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [Abstract] [Full Text] [Related]

  • 3. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P, Zimmerman L, Bergström J.
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [Abstract] [Full Text] [Related]

  • 4. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G, Strecker G, Cueille G, Boudet J, Man NK, Galli A, Agneray J.
    Artif Organs; 1981 Apr; 4 Suppl():17-21. PubMed ID: 7295087
    [Abstract] [Full Text] [Related]

  • 5. Methodology for identification of serum middle molecules.
    Buzio C, Montagna G, Calderini C, Manari A, Migone L.
    Artif Organs; 1981 Apr; 4 Suppl():22-7. PubMed ID: 7295090
    [Abstract] [Full Text] [Related]

  • 6. [Determination of "middle molecules" presenting vitamin B12 molecular size in normal and uremic body fluids (author's transl)].
    Cueille G.
    J Chromatogr; 1978 Jul 01; 146(1):55-65. PubMed ID: 670358
    [Abstract] [Full Text] [Related]

  • 7. Characterization of sub-peak b4.2, middle molecule.
    Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL.
    Artif Organs; 1981 Jul 01; 4 Suppl():28-32. PubMed ID: 7295091
    [Abstract] [Full Text] [Related]

  • 8. Uremic middle molecules: separation and quantitation.
    Chapman GV, Farrell PC.
    Artif Organs; 1981 Jul 01; 4 Suppl():160-5. PubMed ID: 7295084
    [Abstract] [Full Text] [Related]

  • 9. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G, Chu J, Liu X, Yuan Z.
    Clin Chim Acta; 2004 Dec 01; 350(1-2):89-98. PubMed ID: 15530464
    [Abstract] [Full Text] [Related]

  • 10. Separation, isolation, and identification of middle molecules.
    Bergström J, Fürst P, Zimmerman L.
    Artif Organs; 1981 Dec 01; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract] [Full Text] [Related]

  • 11. [Medium molecular weight uremic toxins and endogenous polyamines. Behavior of polymorphonuclear leukocyte chemotaxis with respect to chromatographic peaks of dialysate and standard polyamines].
    Stabellini G, Spisani S, Fiocchi O, Stabellini N, Carletti R, Altobelli A, Farinelli A.
    Boll Soc Ital Biol Sper; 1982 Nov 15; 58(21):1418-24. PubMed ID: 7159534
    [Abstract] [Full Text] [Related]

  • 12. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu J, Yuan Z, Liu X, Wu Q, Mi H, He B.
    Clin Chim Acta; 2001 Sep 25; 311(2):95-107. PubMed ID: 11566169
    [Abstract] [Full Text] [Related]

  • 13. Characterization of middle molecule compounds.
    Zimmerman L, Jörnvall H, Bergström J, Fürst P, Sjövall J.
    Artif Organs; 1981 Sep 25; 4 Suppl():33-6. PubMed ID: 7295092
    [Abstract] [Full Text] [Related]

  • 14. Parathyroid hormone immunoreactivity in the plasma filtrate of uremic patients.
    Tsutsumi M, Fukase M, Fujita T, Fujita K, Inoue S, Shin J.
    Miner Electrolyte Metab; 1982 Mar 25; 7(3):146-50. PubMed ID: 7169980
    [Abstract] [Full Text] [Related]

  • 15. Chemical analytic approaches to the definition of uremic toxins.
    Furst P, Bergstrom J, Gordon A, Zimmermann L.
    Ateneo Parmense Acta Biomed; 1975 Mar 25; 46(5):307-16. PubMed ID: 1232992
    [Abstract] [Full Text] [Related]

  • 16. Isolation and identification of canine plasma components suspected as uremic toxins.
    Kawamura M, Ohashi F, Nagata Y, Takai N, Motoie H, Nishimura R, Sasaki N, Takeuchi A.
    J Vet Med Sci; 1993 Apr 25; 55(2):265-70. PubMed ID: 8513007
    [Abstract] [Full Text] [Related]

  • 17. Separation, isolation and amino acid composition of uremic peptides.
    Shaykh M, Dubin A, Dunea G, Mamdani B, Ahmed S.
    Clin Physiol Biochem; 1984 Apr 25; 2(1):1-13. PubMed ID: 6488692
    [Abstract] [Full Text] [Related]

  • 18. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF, Nikolaev VG, Baran EIa, Dudar' IA, Iushko LA.
    Vopr Med Khim; 1988 Apr 25; 34(6):23-6. PubMed ID: 3238937
    [Abstract] [Full Text] [Related]

  • 19. The effect of hemodialysis on endogenous middle molecules in uremic patients.
    Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J.
    Clin Nephrol; 1979 May 25; 11(5):257-66. PubMed ID: 455822
    [Abstract] [Full Text] [Related]

  • 20. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation].
    Buzio C, Dall'Aglio PP, Delmonte G, Montagna G, Migone L.
    Minerva Nefrol; 1979 May 25; 26(1):45-8. PubMed ID: 471320
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.